Advantage Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $203K | Sell |
3,197
-1,126
| -26% | -$71.5K | 0.16% | 145 |
|
|
2019
Q2 | $292K | Sell |
4,323
-265
| -6% | -$17.9K | 0.22% | 85 |
|
|
2019
Q1 | $298K | Sell |
4,588
-272
| -6% | -$17.7K | 0.23% | 79 |
|
|
2018
Q4 | $304K | Buy |
4,860
+903
| +23% | +$56.5K | 0.23% | 77 |
|
|
2018
Q3 | $306K | Buy |
3,957
+1,198
| +43% | +$92.6K | 0.2% | 92 |
|
|
2018
Q2 | $195K | Sell |
2,759
-68
| -2% | -$4.81K | 0.14% | 130 |
|
|
2018
Q1 | $213K | Buy |
2,827
+200
| +8% | +$15.1K | 0.08% | 153 |
|
|
2017
Q4 | $188K | Sell |
2,627
-382
| -13% | -$27.3K | 0.06% | 188 |
|
|
2017
Q3 | $244K | Buy |
3,009
+531
| +21% | +$43.1K | 0.08% | 155 |
|
|
2017
Q2 | $175K | Buy |
2,478
+135
| +6% | +$9.53K | 0.06% | 176 |
|
|
2017
Q1 | $159K | Sell |
2,343
-430
| -16% | -$29.2K | 0.06% | 169 |
|
|
2016
Q4 | $199K | Sell |
2,773
-54
| -2% | -$3.88K | 0.07% | 145 |
|
|
2016
Q3 | $224K | Buy |
2,827
+663
| +31% | +$52.5K | 0.08% | 129 |
|
|
2016
Q2 | $181K | Sell |
2,164
-530
| -20% | -$44.3K | 0.09% | 142 |
|
|
2016
Q1 | $247K | Buy |
2,694
+515
| +24% | +$47.2K | 0.11% | 111 |
|
|
2015
Q4 | $221K | Sell |
2,179
-360
| -14% | -$36.5K | 0.11% | 126 |
|
|
2015
Q3 | $249K | Buy |
2,539
+375
| +17% | +$36.8K | 0.14% | 107 |
|
|
2015
Q2 | $253K | Hold |
2,164
| – | – | 0.12% | 121 |
|
|
2015
Q1 | $212K | Sell |
2,164
-98
| -4% | -$9.6K | 0.12% | 139 |
|
|
2014
Q4 | $213K | Buy |
+2,262
| New | +$213K | 0.16% | 118 |
|